PE35498A1 - Formulacion farmaceutica de famciclovir - Google Patents
Formulacion farmaceutica de famciclovirInfo
- Publication number
- PE35498A1 PE35498A1 PE1997000022A PE00002297A PE35498A1 PE 35498 A1 PE35498 A1 PE 35498A1 PE 1997000022 A PE1997000022 A PE 1997000022A PE 00002297 A PE00002297 A PE 00002297A PE 35498 A1 PE35498 A1 PE 35498A1
- Authority
- PE
- Peru
- Prior art keywords
- famciclovir
- pharmaceutical formulation
- hydroxipropil
- granulate
- cellulose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION EN PORCENTAJE EN PESO, QUE COMPRENDE: a) MAS DE 85% (PREFERIBLEMENTE 91,42%) DE FAMCICLOVIR, b) 2,83% DE HIDROXIPROPIL CELULOSA, c) 5% DE ALMIDON GLICOLATO SODICO, d) 0,75% DE ESTEARATO DE MAGNESIO, Y OPCIONALMENTE, e) HASTA 15% DE LACTOSA ANHIDRA. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE DICHO COMPRIMIDO, QUE CONSISTE EN GRANULAR EL FAMCICLOVIR CON UN EXCIPIENTE TAL COMO LA HIDROXIPROPIL CELULOSA, DESPUES, MEZCLAR EL GRANULADO CON LOS OTROS EXCIPIENTES Y COMPRIMIR AL TAMANO Y PESO APROPIADOS. EL FAMCICLOVIR ES LA FORMA ORAL DEL PENCICLOVIR, COMPUESTO QUE PRESENTA ACTIVIDAD ANTIVIRAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9600847.9A GB9600847D0 (en) | 1996-01-16 | 1996-01-16 | Pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE35498A1 true PE35498A1 (es) | 1998-08-07 |
Family
ID=10787105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1997000022A PE35498A1 (es) | 1996-01-16 | 1997-01-15 | Formulacion farmaceutica de famciclovir |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US6765007B1 (es) |
| EP (1) | EP0874632B1 (es) |
| JP (2) | JP4711360B2 (es) |
| KR (1) | KR100338829B1 (es) |
| CN (1) | CN1132582C (es) |
| AP (2) | AP747A (es) |
| AR (1) | AR005456A1 (es) |
| AT (1) | ATE220910T1 (es) |
| AU (1) | AU713090B2 (es) |
| BG (1) | BG63488B1 (es) |
| BR (1) | BR9706982A (es) |
| CY (1) | CY2390B1 (es) |
| CZ (1) | CZ287205B6 (es) |
| DE (1) | DE69714215T2 (es) |
| DK (1) | DK0874632T3 (es) |
| DZ (1) | DZ2159A1 (es) |
| EA (1) | EA001946B1 (es) |
| EG (1) | EG23684A (es) |
| ES (1) | ES2180922T3 (es) |
| GB (1) | GB9600847D0 (es) |
| HK (1) | HK1016473A1 (es) |
| HU (1) | HU225472B1 (es) |
| IL (1) | IL124913A0 (es) |
| MX (1) | MX9805713A (es) |
| MY (1) | MY127527A (es) |
| NO (1) | NO315689B1 (es) |
| NZ (1) | NZ326769A (es) |
| OA (1) | OA10812A (es) |
| PE (1) | PE35498A1 (es) |
| PL (1) | PL187291B1 (es) |
| PT (1) | PT874632E (es) |
| SK (1) | SK282132B6 (es) |
| TR (1) | TR199800954T2 (es) |
| TW (1) | TW434016B (es) |
| UA (1) | UA63897C2 (es) |
| UY (2) | UY24437A1 (es) |
| WO (1) | WO1997025990A1 (es) |
| ZA (1) | ZA97310B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100136106A1 (en) * | 2005-06-08 | 2010-06-03 | Gary Liversidge | Modified Release Famciclovir Compositions |
| KR101710148B1 (ko) | 2009-06-26 | 2017-02-27 | 타리스 바이오메디컬 엘엘씨 | 이식가능한 약물전달 디바이스에 사용되기 위한 고체 약물 정제 |
| JP2015063521A (ja) * | 2013-09-02 | 2015-04-09 | 科研製薬株式会社 | 高い薬物含有率を有する錠剤及びその製造方法 |
| CN104434852B (zh) * | 2013-09-18 | 2018-11-20 | 北京韩美药品有限公司 | 泛昔洛韦直压片及其制备方法 |
| CN112587491B (zh) * | 2021-01-03 | 2022-08-23 | 迪沙药业集团有限公司 | 一种泛昔洛韦片组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3421800C1 (de) * | 1984-06-12 | 1986-04-17 | Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl | Elastische Walze zum Behandeln einer thermoplastischen Folie |
| DE3582399D1 (de) * | 1984-09-20 | 1991-05-08 | Beecham Group Plc | Purin-derivate und ihre pharmazeutische verwendung. |
| DE69207656T2 (de) * | 1991-01-30 | 1996-10-17 | Wellcome Found | Wasserlösliche tabletten |
| EP0586523A4 (en) | 1991-05-15 | 1995-11-29 | Univ Yale | Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
| GB9303157D0 (en) * | 1993-02-17 | 1993-03-31 | Scotia Holdings Plc | Treatment of a group of related disorders |
| IL111138A (en) | 1993-10-05 | 1997-04-15 | Smithkline Beecham Plc | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia |
| JP3702594B2 (ja) * | 1997-08-07 | 2005-10-05 | 株式会社明電舎 | パラメータ調節方法及び装置 |
-
1996
- 1996-01-16 GB GBGB9600847.9A patent/GB9600847D0/en active Pending
-
1997
- 1997-01-02 AP APAP/P/1997/000911A patent/AP747A/en active
- 1997-01-10 UY UY24437A patent/UY24437A1/es not_active IP Right Cessation
- 1997-01-13 EP EP97901539A patent/EP0874632B1/en not_active Expired - Lifetime
- 1997-01-13 HU HU9901021A patent/HU225472B1/hu unknown
- 1997-01-13 WO PCT/EP1997/000195 patent/WO1997025990A1/en active IP Right Grant
- 1997-01-13 DK DK97901539T patent/DK0874632T3/da active
- 1997-01-13 AU AU15418/97A patent/AU713090B2/en not_active Expired
- 1997-01-13 PT PT97901539T patent/PT874632E/pt unknown
- 1997-01-13 IL IL12491397A patent/IL124913A0/xx not_active IP Right Cessation
- 1997-01-13 AT AT97901539T patent/ATE220910T1/de active
- 1997-01-13 ES ES97901539T patent/ES2180922T3/es not_active Expired - Lifetime
- 1997-01-13 US US09/101,926 patent/US6765007B1/en not_active Expired - Lifetime
- 1997-01-13 CN CN97191703A patent/CN1132582C/zh not_active Expired - Lifetime
- 1997-01-13 CZ CZ19982254A patent/CZ287205B6/cs not_active IP Right Cessation
- 1997-01-13 EA EA199800573A patent/EA001946B1/ru not_active IP Right Cessation
- 1997-01-13 TR TR1998/00954T patent/TR199800954T2/xx unknown
- 1997-01-13 JP JP52569297A patent/JP4711360B2/ja not_active Expired - Lifetime
- 1997-01-13 NZ NZ326769A patent/NZ326769A/xx not_active IP Right Cessation
- 1997-01-13 UA UA98063199A patent/UA63897C2/uk unknown
- 1997-01-13 BR BR9706982A patent/BR9706982A/pt not_active IP Right Cessation
- 1997-01-13 AP APAP/P/1998/001298A patent/AP1114A/en active
- 1997-01-13 DE DE69714215T patent/DE69714215T2/de not_active Expired - Lifetime
- 1997-01-13 SK SK956-98A patent/SK282132B6/sk not_active IP Right Cessation
- 1997-01-13 PL PL97327922A patent/PL187291B1/pl unknown
- 1997-01-13 KR KR1019980705371A patent/KR100338829B1/ko not_active IP Right Cessation
- 1997-01-14 AR ARP970100130A patent/AR005456A1/es active IP Right Grant
- 1997-01-14 TW TW086100335A patent/TW434016B/zh not_active IP Right Cessation
- 1997-01-14 EG EG4697A patent/EG23684A/xx active
- 1997-01-15 DZ DZ970004A patent/DZ2159A1/fr active
- 1997-01-15 MY MYPI97000137A patent/MY127527A/en unknown
- 1997-01-15 ZA ZA9700310A patent/ZA97310B/xx unknown
- 1997-01-15 PE PE1997000022A patent/PE35498A1/es not_active IP Right Cessation
- 1997-05-16 UY UY24556A patent/UY24556A1/es not_active IP Right Cessation
-
1998
- 1998-07-15 MX MX9805713A patent/MX9805713A/es unknown
- 1998-07-15 BG BG102638A patent/BG63488B1/bg unknown
- 1998-07-15 NO NO19983259A patent/NO315689B1/no not_active IP Right Cessation
- 1998-07-16 OA OA9800116A patent/OA10812A/en unknown
-
1999
- 1999-04-08 HK HK99101423A patent/HK1016473A1/xx not_active IP Right Cessation
-
2003
- 2003-11-28 CY CY0300085A patent/CY2390B1/xx unknown
-
2008
- 2008-11-19 JP JP2008295818A patent/JP2009091362A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR018143A1 (es) | Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca | |
| AP2397A (en) | Matrix for sustained, invariant and independent release of active compounds. | |
| KR890001526A (ko) | 경구용 서방성 아세트 아미노펜 제형 및 이의 제조방법 | |
| AR054782A2 (es) | Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico | |
| KR840005661A (ko) | 지속성 매트릭스 정제 조성물의 제조방법 | |
| AR037930A1 (es) | Formulaciones de acitromicina directamente compresibles | |
| IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
| AR054382A1 (es) | Formulacion de compresion directa de un inhibidor de dipeptidil-peptidasa iv y una glitazona y proceso | |
| MY137768A (en) | Rapidly disintegrating methylcellulose tablets | |
| RU2008107580A (ru) | Составы, содержащие базедоксифен ацетат | |
| MY128046A (en) | Rapidly disintegrating methylcellulose tablets | |
| CO5390076A1 (es) | Composiciones farmaceuticas | |
| PE20040496A1 (es) | Tabletas dispersables que comprenden un derivado de acido benzoico | |
| EP0009688A3 (en) | Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases | |
| GB1296505A (es) | ||
| AR011919A1 (es) | FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA | |
| ATE219061T1 (de) | Huperzin a analoge verbindungen | |
| DE69211688T2 (de) | Kaubare antacida | |
| PE35498A1 (es) | Formulacion farmaceutica de famciclovir | |
| CA2531853A1 (en) | Pharmaceutical formulation comprising levothyroxine sodium | |
| ES2099021B1 (es) | Composicion farmaceutica que tiene actividad analgesica. | |
| AR021086A1 (es) | Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento. | |
| BR0013106A (pt) | Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido. | |
| CA2502582A1 (en) | Pharmaceutical formulation of olanzapine | |
| ES2060417T3 (es) | Procedimiento para la preparacion por compresion directa de comprimidos de derivados del acido cefalosporanico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| MK | Expiration of term |